228547-63-5

Basic information

• Product Name: 1,2,3-Oxathiazolidine, 4,4-dimethyl-3-(phenylmethyl)-, 2-oxide
• CAS NO: 228547-63-5
• Molecular Formula: C11H15NO2S
• Molecular Weight: 225.312
• Mol File: 228547-63-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1,2,3-Oxathiazolidine, 4,4-dimethyl-3-(phenylmethyl)-, 2-oxide(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3-Oxathiazolidine, 4,4-dimethyl-3-(phenylmethyl)-, 2-oxide(228547-63-5)
• EPA Substance Registry System: 1,2,3-Oxathiazolidine, 4,4-dimethyl-3-(phenylmethyl)-, 2-oxide(228547-63-5)

Safety Data

• Hazardous Substances Data: 228547-63-5(Hazardous Substances Data)

Upstream product

• 100-52-7 benzaldehyde 
• 10250-27-8 2-benzylamino-2-methyl-1-propanol 
• 22563-90-2 2-Benzalamino-isobutanol 

Downstream Products

• 228547-65-7 N-benzyl-2-amino-1-fluoro-2-methylpropane 
• 228547-64-6 3-benzyl-4,4-dimethyl-[1,2,3]-oxathiazolidine-2,2-dioxide 

Relevant articles and documents

Facile synthesis of β-amino disulfides, cystines, and their direct incorporation into peptides

Herein, we report a simple and efficient methodology for the synthesis of β-amino disulfides by regioselective ring opening of sulfamidates with benzyltriethylammonium tetrathiomolybdate [BnNEt3] 2MoS4. Stability and reactivity of different protecting groups under the reaction conditions have been discussed. This methodology has also been extended to serine and threonine derived sulfamidates to furnish cystine and 3,3′-dimethyl cystine derivatives. Georg Thieme Verlag.

AMIDOPYRAZOLE DERIVATIVE

A platelet coagulation inhibitor which inhibits neither COX-1 nor COX-2 is provided. The inhibitor is a compound represented by general formula (I): wherein Ar1 and Ar2 independently represent a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents, or a phenyl group optionally substituted with 1 to 3 substituents; R1 represents a lower acyl group, carboxyl group, a lower alkoxycarbonyl group, a lower alkoxy group, a lower alkyl group optionally substituted with 1 or 2 substituents, a carbamoyl group optionally substituted with 1 or 2 substituents, an oxamoyl group optionally substituted with 1 or 2 substituents, an amino group optionally substituted with 1 or 2 substituents, a 4- to 7-membered alicyclic heterocyclic group optionally substituted with 1 or 2 substituents, a phenyl group optionally substituted with 1 to 3 substituents, or a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents; and R2 represents hydrogen atom, a halogeno group, or the like.

Progress in the synthesis of [18-F]-fluoroamines; precursors to β-selective andrenergic ligands

-